Search results for " Chinese Traditional"

showing 10 items of 28 documents

A review on the phytopharmacological studies of the genus Polygala

2020

Abstract Ethnopharmacological relevance The genus Polygala, the most representative genus of the Polygalaceae family, comprises more than 600 species from all over the world of which around 40 are distributed in China, some of them, being used in the Traditional Chinese Medicine system. Aim of the review We intend to discuss the current knowledge about the traditional uses, and the newest phytochemical and pharmacological achievements with tentative elucidation of the mechanism of action on the genus Polygala covering the period 2013–2019 to provide a scientific support to the traditional uses, and to critically analyze the reported studies to obtain new insights for further researches. Mat…

ChinaPolygala[SDV]Life Sciences [q-bio]Traditional Chinese medicine03 medical and health sciences0302 clinical medicineGenusDrug DiscoveryAnimalsHumansMedicine Chinese Traditional030304 developmental biologyPharmacology0303 health sciencesbiologyTraditional medicinebiology.organism_classificationPolygala3. Good healthDisease Models AnimalPhytochemical030220 oncology & carcinogenesisEthnopharmacologyElectronic dataPolygalaceaePlant PreparationsEnzyme inhibitoryPhytotherapyJournal of Ethnopharmacology
researchProduct

Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor

2010

The epidermal growth factor receptor (EGFR) has become an important molecular target in cancer therapy. Various small molecules and therapeutic antibodies targeting EGFR family members have been developed during recent years and are established in clinical oncology. However, increasing clinical application of EGFR tyrosine kinase inhibitors has resulted in the development of resistance to EGFR-targeting drugs due to the selection of EGFR-mutated variants. This phenomenon forced the search for novel EGFR inhibitors with activity towards EGFR-mutant tumors. This review describes recent achievements in natural products derived from medicinal plants as novel EGFR inhibitors.

Clinical OncologyPlants MedicinalbiologyOrganic ChemistryCancer therapyGeneral MedicineTraditional Chinese medicinePharmacologyAntineoplastic Agents PhytogenicSmall moleculeComputer Science ApplicationsErbB ReceptorsNeoplasmsDrug DiscoveryMolecular targetsbiology.proteinAnimalsHumansEpidermal growth factor receptorMedicine Chinese TraditionalEGFR FamilyDrugs Chinese HerbalEGFR inhibitorsCombinatorial Chemistry & High Throughput Screening
researchProduct

Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours.

2009

Scientific progress in genetics, cell and molecular biology has greatly ameliorated our comprehensive understanding of the molecular mechanisms of neoplastic transformation and progression. The rapidly advancing identification of molecular targets in human cancers during the last decade has provided an excellent starting point for the development of novel therapeutics. A huge variety of potential molecular targets have been identified, many of which are already in the market for therapeutic purposes. It is now becoming possible to target pathways and/or molecules that are crucial in maintaining the malignant phenotype. Traditional Chinese medicine (TCM) is often considered as alternative or…

Complementary TherapiesModern medicineCurcuminBerberineArtesunateMolecular Targeted TherapiesTraditional Chinese medicineComputational biologyPharmacologyModels BiologicalArsenicalsScientific evidenceDrug Delivery SystemsArsenic TrioxideNeoplasmsDrug DiscoveryMedicineAnimalsHumansNeoplastic transformationMedicine Chinese TraditionalMalignant phenotypeBiological ProductsScientific progressbusiness.industryOxidesAntineoplastic Agents PhytogenicArtemisininsCantharidinIdentification (biology)Drug Screening Assays AntitumorbusinessDrugs Chinese HerbalCurrent drug discovery technologies
researchProduct

Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement

2015

Hemorrhoids are one of the most common medical and surgical diseases and the main reason for a visit to a coloproctologist. This consensus statement was drawn up by the Italian society of colorectal surgery in order to provide practice parameters for an accurate assessment of the disease and consequent appropriate treatment. The authors made a careful search in the main databases (MEDLINE, PubMed, Embase and Cochrane), and all results were classified on the basis of the grade of recommendation (A-C) of the American College of Chest Physicians.

Dietary FiberMaleHemorrhoidectomymedicine.medical_specialtyStatement (logic)Infrared Raysmedicine.medical_treatmentSettore MED/18 - CHIRURGIA GENERALEMEDLINEAnal CanalDiseaseHemorrhoidsHemorrhoidsPregnancySclerotherapymedicineSclerotherapyHumansDisease management (health)Medicine Chinese TraditionalLigationDigestive System Surgical ProceduresHemorrhoidectomy; Hemorrhoids; Anal Canal; Colorectal Surgery; Diet; Dietary Fiber; Digestive System Surgical Procedures; Female; Hemorrhoidectomy; Hemorrhoids; Humans; Infrared Rays; Italy; Laser Coagulation; Ligation; Male; Medicine Chinese Traditional; Pregnancy; Pregnancy Complications; Sclerotherapy; Disease Management; Gastroenterology; Surgery; Medicine (all)Laser Coagulationbusiness.industryGeneral surgeryMedicine (all)GastroenterologyDisease ManagementDigestive System Surgical ProcedureInfrared Raymedicine.diseaseColorectal surgeryPregnancy ComplicationSurgeryDietPregnancy ComplicationsItalyFemaleSurgerybusinessHemorrhoidColorectal SurgeryAbdominal surgeryHuman
researchProduct

The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion.

2019

1. Preamble : Hypercholesterolemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD) [1]. Increased levels of low density lipoprotein cholesterol (LDL-C) are associated with an increased risk of coronary heart disease (CHD) and many clinical trials have shown that reducing LDL-C levels significantly reduced the CHD and CVD risk [[2], [3], [4], [5]]. Thus LDL-C-lowering is the main approach for the management of cardiovascular disease. Current guidelines suggest LDL-C levels targets based on the individual CV risk; such targets can be achieved by several means, which include both lifestyle changes and pharmacological approaches [6], with statins being the cornerstone …

Gastrointestinal Diseases[SDV]Life Sciences [q-bio]Hypercholesterolemia/Self Medication030204 cardiovascular system & hematologyPharmacology03 medical and health sciencesFood-Drug Interactions0302 clinical medicinePlasma cholesterolBiotransformationDouble-Blind MethodChinese traditionalInternal MedicineRed yeast riceMedicineCytochrome P-450 CYP3AHumansMulticenter Studies as TopicProdrugs030212 general & internal medicineLovastatinMusculoskeletal DiseasesMedicine Chinese TraditionalExpert TestimonyComputingMilieux_MISCELLANEOUSBiotransformationRandomized Controlled Trials as TopicBiological ProductsClinical Trials as TopicMolecular StructureRyanodine receptorbusiness.industryGeneral Medicine3. Good healthCholesterol blood[SDV] Life Sciences [q-bio]CholesterolCardiovascular DiseasesExpert opinionDietary Supplementslipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular Medicinebusiness
researchProduct

An investigation of the pharmacological applications used for the Ancient Egyptian systemic model ‘ra-ib’ compared with modern Traditional Chinese Me…

2020

Abstract Ethnopharmacological relevance Ancient Egyptian texts only offer glimpses into their conceptual understandings of the inner-body and illness manifestation. Explanations of how prescribed materia medica were believed to work are rare and obscure, often resulting in modern approximations for ancient terminology such as ‘ra-ib’—an ancient Egyptian classification predominantly translated as ‘stomach’—leading to misunderstandings of historical texts, and therefore their use of pharmacology. Aim of the study To investigate the ra-ib and the explanatory models of illness from the Egyptian perspective, and to explore the link between these and the prescribed selection of materia medica. To…

HistoryEgypt AncientMateria medicalaw.inventionTerminology03 medical and health sciences0302 clinical medicinelawDrug DiscoverySelection (linguistics)HumansRelevance (law)Medicine Chinese TraditionalHistory Ancient030304 developmental biologyPharmacopoeias as TopicPharmacology0303 health sciencesEpistemologyAncient Egyptian medicinePhilologyConceptual framework030220 oncology & carcinogenesisEthnopharmacologyMateria MedicaPharmacopoeiaDrugs Chinese Herbal
researchProduct

Traditional Chinese Medicine (TCM) for fibrotic liver disease: Hope and hype

2014

Liver Cirrhosismedicine.medical_specialtyCirrhosisMEDLINEHolistic HealthTraditional Chinese medicineHolistic healthGastroenterologyHepatitisLiver diseaseFibrosisInternal medicineChinese traditionalHBVmedicineHumansMedicine Chinese TraditionalIntensive care medicineInflammationHepatitisClinical Trials as TopicHerbHepatologybusiness.industryNASHmedicine.diseaseFibrosisTCMCirrhosisLiverHCVCollagenAntifibroticbusinessDrugs Chinese HerbalJournal of Hepatology
researchProduct

Acylated triterpene saponins from Silene jenisseensis

1995

Abstract From the roots of Silene jenisseensis a new trans-p-methoxycinnamoyl triterpene saponin has been isolated along with its cis-p-methoxycinnamoyl isomer as an inseparable mixture. Their structures were established by chemical means and spectroscopic methods including 1D- and 2D-homonuclear and heteronuclear correlation NMR spectroscopy as 3-O-[β- d -galactopyranosyl -(1 → 2)-β- d -glucuronopyranosyl ]-28-O-[β- d -glucopyranosyl -(1 → 2)-α- l - rhamnopyranosyl -(1 → 2)-β- d -4-O-trans-p- methoxycinnamoyl-fucopyranosyl ] quillaic acid and its cis-isomer, respectively. They did not show any activity in the in vitro chemoluminescence granulocytes assay, but exhibited only a weak inhibito…

Magnetic Resonance SpectroscopyStereochemistryAcylationMolecular Sequence DataSaponinCaryophyllaceaePlant ScienceHorticulturePlant RootsBiochemistrylaw.inventionTriterpenelawCarbohydrate ConformationHumansMoleculeMedicine Chinese TraditionalOleanolic AcidMolecular BiologyChemiluminescencechemistry.chemical_classificationPlants MedicinalbiologyChemistryGeneral MedicineNuclear magnetic resonance spectroscopySaponinsbiology.organism_classificationTriterpenesIn vitroCarbohydrate SequenceHeteronuclear moleculeLuminescent MeasurementsGranulocytesPhytochemistry
researchProduct

Inhibition of Trypanosoma cruzi by plant extracts used in Chinese medicine.

2004

In this work, we assessed the effect of extracts obtained from 17 plants used in traditional Chinese medicine. These extracts were tested in vitro with the epimastigote form of Trypanosoma cruzi, clone Bra C(15) C(2), at 27 degrees C in F-29 medium at a concentration of 100 microg/ml in axenic cultures. Allopurinol was used as reference drug. Seven plant extracts showed inhibitory activities lower than 25%. Pueraria lobata, Mahonia beaei, Dictamus dasycarpus, Kochia scoparia, Sophora flavescens and Ligustrum lucidum showed effects with inhibition values between 25% and 60%, whereas Lithospermum erythrorhizon, Saussurea lappa, Melia toosendan and Cinnamomum cassia showed the greatest inhibit…

MalePuerariaTrypanosoma cruziMahoniaPharmacognosyPlant RootsInhibitory Concentration 50Parasitic Sensitivity TestsCassiaDrug DiscoveryAnimalsMedicine Chinese TraditionalRats WistarPharmacologySophora flavescensPlants MedicinalbiologyTraditional medicinePlant StemsPlant ExtractsGeneral Medicinebiology.organism_classificationLithospermum erythrorhizonTrypanocidal AgentsRatsFruitSeedsPlant BarkScopariaRhizomeCinnamomumPhytotherapyFitoterapia
researchProduct

Inhibition of Trypanosoma cruzi growth by medical plant extracts

2002

This study describes the screening of extracts obtained from 18 plants and two fungi used in the Chinese and Mediterranean traditional medicines on epimastigote forms of Trypanosoma cruzi. The extracts were tested against epimastigote of T. cruzi Bra C15C2 clone in vitro at 27 degrees C and at a concentration of 250 microg/ml in axenic culture. Angelica dahurica, A. pubescens, A. sinensis, Astragalus membranaceus, Coptis chinensis, Haplophyllum hispanicum, Phellodendron amurense, Poria cocos, Ranunculus sceleratus and Scutellaria baicalensis showed significant effects against the parasite with a percentage of growth inhibition between 20 and 100%. C. chinensis and R. sceleratus showed the g…

MaleTrypanosoma cruziPharmacognosyInhibitory Concentration 50chemistry.chemical_compoundDrug DiscoveryLeukocytesAnimalsRanunculus sceleratusMedicine Chinese TraditionalRats WistarTrypanosoma cruziPharmacologyPlants MedicinalDose-Response Relationship DrugbiologyTraditional medicineMediterranean RegionPlant ExtractsAngelica dahuricaFungiGeneral MedicineAstragalus propinquusCoptis chinensisbiology.organism_classificationRatsLogistic ModelschemistryPhellodendron amurenseScutellaria baicalensisMedicine TraditionalGrowth inhibitionFitoterapia
researchProduct